The court's order
The closing paragraphs of the judgment, in the court's own words. The reasons are in the full text below.
19. The impugned order thus suffers from material illegality and is in violation of the principle of natural justice. No meaningful opportunity of hearing can be said to have been granted to the petitioner in absence of the material which forms basis of the impugned action. The impugned order, therefore, deserves to be set aside. The same is accordingly set aside.
20. The respondents, however, are granted liberty to supply a copy of the test report and to enable the petitioner to exercise the right of controversion and to take the matter to its logical end without being influenced by any of the observations made herein.
21. With the aforesaid direction, the petition stands disposed of alongwith the pending application.
Full Judgment Text
Text read from the judgment PDF published on the High Court's eCourts portal, through the
Indian High Court Judgments open data set (Dattam Labs,
CC BY 4.0).
The court's own copy is the authoritative text.
*
IN THE HIGH COURT OF DELHI AT NEW DELHI
+
W.P.(C) 15121/2025 & CM APPL. 62126/2025
M/S EUROLIFE HEALTHCARE PRIVATE LIMITED
Through:
.....Petitioner
Mr. M. Sufian Siddiqui, Mr. Rakesh
Bhugra and Mr. Mohammad Mazhar
Ahmed, Advs.
versus
UNION OF INDIA & ANR.
Through:
.....Respondents
Dr. B. Ramswamy, CGSC.
CORAM:
HON’BLE MR. JUSTICE PURUSHAINDRA KUMAR KAURAV
ORDER
06.01.2026
%
1.
This petition is directed against the impugned order of debarment
dated 11.08.2025, passed by the Office of the Director General Armed
Forces Medical Services (DGAFMS), New Delhi. The petitioner claims to
be a WHO-GMP and CDSCO-certified pharmaceutical manufacturer of
international repute and is engaged, inter alia, in the supply of life-saving
infusions to the Armed Forces over 36 countries worldwide.
2.
The instant petition relates to the product Compound Sodium Lactate
injection I.P. and specifically to batch no.DCSL3021 in favour of the
petitioner’s authorized distributor through Shri Sai Agencies. The total
quantity ordered was 10,000 units, which was duly supplied through two
batches i.e., Batch No. DCSL3020 (4,150 units) and Batch No. DCSL3021
(5,850 units).
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 12/01/2026 at 13:00:24
3.
It is the case of the petitioner that there was no quality complaint or
any issue ever raised by the respondents at any point of time. However, the
respondents, by way of the impugned order, have debarred the petitioner
without affording a full opportunity of hearing.
4.
Mr. M. Sufian Siddiqui, learned counsel appearing for the petitioner
has submitted that the impugned order clearly refers to a ‘lab test report’,
and a copy of which has not been supplied to the petitioner. He contends that
the show cause notice and the petitioner’s reply to the same were
meaningless, in absence of a copy of the report having been supplied to the
petitioner.
5.
Learned counsel has also referred various decisions of the Court,
however, reference thereto may not be necessary for the nature of the
directions which the Court proposes to be issued.
6.
Dr. B. Ramswamy, learned counsel appearing for the respondents,
strongly opposes the aforesaid submissions and has relied upon the
averments made in the counter affidavit filed by the respondents. He has
specifically taken the Court through paragraph Nos.42 to 45, 46 to 47 and 51
to 54. According to him, a copy of the test report by the Central Drugs
Laboratory, Kolkata has not been supplied.
7.
Dr. Ramswamy submits that the Supreme Court, in the case of Amery
Pharmaceuticals and Ors. v. State of Rajasthan,1 has unequivocally held
that there is no necessity to supply the test report and hence, in the instant
case, the authorities have made it clear that in case the petitioner so desires,
it may take recourse to the exercise under Section 25(3) of the Drugs and
2001 4 SC 382
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 12/01/2026 at 13:00:24
Cosmetics Act, 1940 [‘Act’] post decision. He also submits that a show
cause notice was issued, and the petitioner’s reply was considered. Further,
the representation of the petitioner was made before the meeting of the
Department. According to him, the impugned order is justified and does not
call for any inference.
8.
I have considered the submissions made by learned counsel appearing
for the parties and have perused the record.
9.
A reading of the impugned order dated 11.08.2025 would indicate that
the show cause notice was issued to the petitioner on 03.07.2025 and the
response thereto was received. It is, thereafter, that the meeting was
conducted on 04.08.2025 at the Office of DGAFMS, New Delhi.
10.
The plea of the petitioner appears not to have been accepted by the
competent authority. However, the petitioner has been advised to take up the
matter for retesting as per Section 25 of the Act, if the petitioner is not in
agreement with the result of the first test report.
11.
The impugned order further states that, awaiting the report or the steps
to be taken by the petitioner, punitive action may not be held up and hence,
the petitioner has been debarred for a period of two years from the date of
passing of the order. For the sake of clarity, the impugned order is extracted
below, for reference:
“DEBARMENT OF PVMS NO 270724 COMPOUNDSODIUM LACTATE
INJ IP BEARING BATCH NO DCSL-3021, D/M 11/2023, D/E 10/2026
MFG BY M/S EUROLIFE HEALTHCARE PVT LTD, DECLARED AS
“NOT OF STANDARD QUALITY”
1. Refer to this office 5567/DGAEMS/DG-2/PCMC/Eurolife/2025:dt
03;Jul 2025, your firm letter No EHPL DGAFMS/04/2025-2026 dt
07/07/2025 and meeting between ADG (E&S) and Mr Shamim Akhtar,
General Manager of your firm on 04 Aug 2025 at office of the DGAFMS,
New Delhi.
2 Plea of your firm through letter under reference and submission during
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 12/01/2026 at 13:00:24
aforesaid meeting has not been accepted by competent authority.
However, your firm is advised to take up the matter for retesting as per
Section 25 of the Drugs and Cosmetic Act 1940 if, your firm is not in
agreement with the result of the first test report Punitive action as stated at
Para 4 of ibid Show Cause Notice may not be held up because of the same.
However, as and when the report of re-testing is received from - appellate
authority, the debarment status of subject, drug may be reviewed
accordingly by this office. It has been further advised that testing by NABL
Labs in this case is not acceptable
3. In view of the above, subject drug of your firm is debarred for two years
as per extant policy and instructions have been issued that neither any
fresh tender nor supply order will be issued in favour of your firm for
subject drug during the debarment period or recovery of the entire cost of
the defective batch from your firm, whichever is later.In this, connection
please refer to Para 3.5.1 of DPM 2009 & Para 5 (a) & (c) of DoE, MoF
O.M. No. F.1/20/2018-PPD dated 02 Nov 2021.”
12.
If the reply to the show cause notice is perused, it would indicate that
the petitioner had sought immediate retesting of the retention samples of the
concerned batch at any alternate CDL or approved
NABL-accredited
laboratory at the petitioner’s cost. Even in Annexure P-17 , which an e-mail
by the petitioner dated 05.08.2025, the aforesaid request was reiterated. This
seems to be after the meeting was conducted.
13.
It is thus seen that the petitioner, right from the inception, was
requesting for retesting of the sample and had not accepted the report of the
concerned lab. Even otherwise, a perusal of the material would clearly
indicate that the report of the lab has never been supplied to the petitioner.
14.
The reply of the paragraph nos.51 to 54 of respondent No.1 reinforces
the aforesaid position, which states that as per Section 25 (3) and (4) of the
Act power to allow retesting is vested in the Drug Inspector or the Court.
The respondents do not dispute the right of the petitioner for getting the
sample retested, however, what is contended is that the aforesaid right can
be exercised post decision.
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 12/01/2026 at 13:00:24
15.
The averments made in the reply to paragraph Nos.46 to 47 of the
petition will also have relevance and accordingly, the same is extracted
below, for reference:
“Para 46 to 47- The petitioner's claim of violation of natural justice and
denial of the statutory right to appellate retesting under Section 25 of the
Drugs and Cosmetics Act is wholly misplaced as the debarment order was
passed after due consideration of the available test report and after
affording opportunity to the petitioner through Show Cause Notice dated
03.07.2025, to explain and rebut the test findings. s. / The office held
meeting with the petitioner's representatives, including documented
minutes, to encourage all remedies available under Section 25 of the
Drugs and Cosmetics Act, 1940 and ensure statutory safeguards. The
contention that the petitioner was denied Form 13 or the complete analysis
report is refuted. The said documents were provided, albeit belatedly, and
any delay in furnishing the documents does not vitiate the legality of the
impugned order especially when the petitioner failed to timely (pursue its
appellate rights. Moreover, the firm was aware of the matter since Mar
2025 as evident from the letter dated 31.03.2025 addressed to the Deputy
Drugs Controller (India), &W Delhi by the firm. The petitioner's assertion
that the ) Barment was imposed without allowing retesting is incorrect
The petitioner was advised in the impugned order that it could seek
retesting under Section 25 if dissatisfied with the test results and the
debarment was made subject to the outcome of such retesting.
Para 48- That in reply to the contents of Para, it is submitted that the
contents of this Para need no reply from the Respondent No 1 as these are
pertaining to CDSCO (Respondent No 02).”
16.
A cumulative reading of the material would thus establish that the lab
report remains unserved to the petitioner.
17.
If Section 25(3) of the Act is perused, it would indicate that any
document purporting to be a report signed by Government Analyst under
Chapter-IV shall be evidence of the facts stated therein, and such evidence
shall be conclusive unless the person from whom the smaple was taken or
the person whose name, address and other particulars have been disclosed
under section 18A has, within twenty-eight days of the receipt of a copy of
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 12/01/2026 at 13:00:24
the report, notified in writing to the Inspector or the Court before which any
proceedings in respect of the sample are pending that he intends to adduce
evidence in controversion of the report.
18.
In the instant case, what assumes significance is the fact that the right
to controvert the report has not yet commenced and punitive action has
already been taken by the respondents. As on date, no proceeding pertaining
to the report remains pending before any Court. What is assailed by the
petitioner is the decision taken on the basis of the report. Since, till date, the
report has not been supplied to the petitioner, therefore, the petitioner has
not been able to exercise its right of controversion to the said report vested
under Section 25(3) of the Act.
19.
The impugned order thus suffers from material illegality and is in
violation of the principle of natural justice. No meaningful opportunity of
hearing can be said to have been granted to the petitioner in absence of the
material which forms basis of the impugned action. The impugned order,
therefore, deserves to be set aside. The same is accordingly set aside.
20.
The respondents, however, are granted liberty to supply a copy of the
test report and to enable the petitioner to exercise the right of controversion
and to take the matter to its logical end without being influenced by any of
the observations made herein.
21.
With the aforesaid direction, the petition stands disposed of alongwith
the pending application.
PURUSHAINDRA KUMAR KAURAV, J
JANUARY 6, 2026/p/amg
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above.
The Order is downloaded from the DHC Server on 12/01/2026 at 13:00:24
This page is for informational and research purposes only and does not constitute legal advice.
Consult a qualified advocate for advice specific to your situation.
Is your name in this judgment and should it be masked, or is something on this page wrong?
Request a review